Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

New anticoagulant prompts bad blood between partners.

Friedly J.

Science. 1996 Mar 29;271(5257):1800-1. No abstract available.

PMID:
8596945
2.

An anticoagulant peptide from the human hookworm, Ancylostoma duodenale that inhibits coagulation factors Xa and XIa.

Gan W, Deng L, Yang C, He Q, Hu J, Yin H, Jin X, Lu C, Wu Y, Peng L.

FEBS Lett. 2009 Jun 18;583(12):1976-80. doi: 10.1016/j.febslet.2009.05.009. Epub 2009 May 14.

3.

Molecular characterization of Ancylostoma inhibitors of coagulation factor Xa. Hookworm anticoagulant activity in vitro predicts parasite bloodfeeding in vivo.

Harrison LM, Nerlinger A, Bungiro RD, Córdova JL, Kuzmic P, Cappello M.

J Biol Chem. 2002 Feb 22;277(8):6223-9. Epub 2001 Dec 7.

4.

A new factor Xa inhibitor (lefaxin) from the Haementeria depressa leech.

Faria F, Kelen EM, Sampaio CA, Bon C, Duval N, Chudzinski-Tavassi AM.

Thromb Haemost. 1999 Nov;82(5):1469-73.

PMID:
10595640
5.

HGS seeks exclusive option on all patents using its cDNA sequences.

Dickson D.

Nature. 1994 Oct 6;371(6497):463. No abstract available.

PMID:
7935747
6.
7.

Are ESTs patentable?

Auth DR.

Nat Biotechnol. 1997 Sep;15(9):911-2. No abstract available.

PMID:
9306410
8.

Universities plan to speed sale of biotechnology.

[No authors listed]

New Sci. 1983 Mar 17;97(1349):704. No abstract available.

PMID:
11655523
9.

A novel anticoagulant protein from Scapharca broughtonii.

Jung WK, Je JY, Kim HJ, Kim SK.

J Biochem Mol Biol. 2002 Mar 31;35(2):199-205.

10.

A family of galectins from Haemonchus contortus.

Greenhalgh CJ, Loukas A, Donald D, Nikolaou S, Newton SE.

Mol Biochem Parasitol. 2000 Mar 15;107(1):117-21. No abstract available.

PMID:
10717307
11.

Purification, characterization and cDNA cloning of a novel anticoagulant of the intrinsic pathway, (prolixin-S) from salivary glands of the blood sucking bug, Rhodnius prolixus.

Sun J, Yamaguchi M, Yuda M, Miura K, Takeya H, Hirai M, Matsuoka H, Ando K, Watanabe T, Suzuki K, Chinzei Y.

Thromb Haemost. 1996 Apr;75(4):573-7.

PMID:
8743181
12.

Closer university-industry links.

Humphreys G.

Biochem Soc Trans. 1990 Aug;18(4):533-5. No abstract available.

PMID:
2276427
13.

Statement from Peter Seeburg.

Seeburg PH.

Nature. 1999 May 27;399(6734):298. No abstract available.

PMID:
10360565
14.

Anticoagulant properties of a sulfated galactan preparation from a marine green alga, Codium cylindricum.

Matsubara K, Matsuura Y, Bacic A, Liao M, Hori K, Miyazawa K.

Int J Biol Macromol. 2001 Jun 12;28(5):395-9.

PMID:
11325427
15.

Does biotechnology have a price?

[No authors listed]

Nature. 1982 Apr 8;296(5857):479-80. No abstract available.

PMID:
11643737
16.

Patenting nanotechnology.

Lemley MA.

Stanford Law Rev. 2005 Nov;58(2):601-30.

PMID:
16395838
17.

Property claims. A deluge of patents creates legal hassles for research.

Marshall E.

Science. 2000 Apr 14;288(5464):255-7. No abstract available.

PMID:
10777404
18.

The commercialization of biotechnology: important aspects of technology licensing.

Irvine S.

Aust J Biotechnol. 1991 Apr;5(2):105-8. No abstract available.

PMID:
1367321
19.

Intellectual property. Research centers promise a break on medical patents in developing countries.

Kean S.

Science. 2009 Nov 20;326(5956):1051. doi: 10.1126/science.326.5956.1051-a. No abstract available.

PMID:
19965400
20.

Industry funds in universities: new guidelines emerge from Pajaro Dunes.

Dickson D.

Nature. 1982 Apr 1;296(5856):381-2.

PMID:
11643726
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk